| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00001756-199808030-00001 |
| P698 | PubMed publication ID | 9721909 |
| P50 | author | Richard Faull | Q28101943 |
| P2093 | author name string | C E Williams | |
| P E Hughes | |||
| T Alexi | |||
| P433 | issue | 11 | |
| P921 | main subject | neurodegeneration | Q1755122 |
| P304 | page(s) | R57-64 | |
| P577 | publication date | 1998-08-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | NeuroReport | Q15710007 |
| P1476 | title | 3-Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration | |
| P478 | volume | 9 |
| Q37718532 | 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future. |
| Q44088762 | 3-Nitropropionic acid induces cell death and mitochondrial dysfunction in rat corticostriatal slice cultures |
| Q73342059 | 3-Nitropropionic acid: an astrocyte-sparing neurotoxin in vitro |
| Q43825303 | 3‐Ureidopropionate contributes to the neuropathology of 3‐ureidopropionase deficiency and severe propionic aciduria: A hypothesis |
| Q45303159 | 4-hydroxy tempo improves mitochondrial and neurobehavioral deficits in experimental model of Huntington's disease. |
| Q38922040 | A tale of four kingdoms - isoxazolin-5-one- and 3-nitropropanoic acid-derived natural products |
| Q41841066 | Acute and long‐term response of dopamine nigrostriatal synapses to a single, low‐dose episode of 3‐nitropropionic acid‐mediated chemical hypoxia |
| Q42517324 | Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease. |
| Q44535350 | Ammonia potentiates methylmalonic acid-induced convulsions and TBARS production |
| Q27015535 | Animal models of multiple system atrophy |
| Q45061031 | Antioxidant effects of taurine, vitamin C, and vitamin E on oxidative damage in hippocampus caused by the administration of 3-nitropropionic acid in rats |
| Q43252987 | Antioxidant strategy to rescue synaptosomes from oxidative damage and energy failure in neurotoxic models in rats: protective role of S-allylcysteine |
| Q33954091 | Basal ganglia neurotoxins |
| Q46863278 | Behavioral alterations in Lewis rats following two-day continuous 3-nitropropionic acid administration |
| Q43694197 | Behavioural correlates of striatal glial fibrillary acidic protein in the 3-nitropropionic acid rat model: disturbed walking pattern and spatial orientation |
| Q37253331 | Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease. |
| Q36045364 | Cell therapy in Huntington's disease. |
| Q58691859 | Cilostazol disrupts TLR-4, Akt/GSK-3β/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease |
| Q88810196 | Comparison of the Toxic Effects of Quinolinic Acid and 3-Nitropropionic Acid in C. elegans: Involvement of the SKN-1 Pathway |
| Q43902557 | Concentrations of different sterols in the striatum and serum of 3-nitropropionic acid-treated Wistar and Lewis rats |
| Q33459255 | Conformational targeting of fibrillar polyglutamine proteins in live cells escalates aggregation and cytotoxicity |
| Q43687507 | Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington's disease |
| Q42526044 | Cytoplasmic calcium mediates oxidative damage in an excitotoxic /energetic deficit synergic model in rats. |
| Q34374500 | DYT1 knock-in mice are not sensitized against mitochondrial complex-II inhibition |
| Q42488140 | Differentially displayed genes in neuroblastoma cells treated with a mitochondrial toxin: evidence for possible involvement of ICAM-1 in 3-nitropropionic acid-mediated neurodegeneration |
| Q45946973 | Early nerve ending rescue from oxidative damage and energy failure by L: -carnitine as post-treatment in two neurotoxic models in rat: recovery of antioxidant and reductive capacities. |
| Q48402575 | Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats |
| Q44722641 | Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington's disease: a preliminary study |
| Q52893173 | Effects of acute systemic 3-nitropropionic acid administration on rat activity and acoustic startle |
| Q43919423 | Evaluation of 3-nitrotyrosine as a marker for 3-nitropropionic acid-induced oxidative stress in Lewis and Wistar rats and strain-specific whole brain spheroid cultures |
| Q46808934 | Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine |
| Q43774443 | Excretion of miserotoxin and detoxification of the aglycone by grasshoppers (Orthoptera: Acrididae) |
| Q39123661 | Induction of apoptosis by antimycin A in differentiated PC12 cell line |
| Q48432469 | Infant mice with glutaric acidaemia type I have increased vulnerability to 3-nitropropionic acid toxicity. |
| Q28386928 | Involvement of the Up-regulated FoxO1 Expression in Follicular Granulosa Cell Apoptosis Induced by Oxidative Stress |
| Q42177440 | Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors |
| Q42444390 | Lipid peroxidation, mitochondrial dysfunction and neurochemical and behavioural deficits in different neurotoxic models: protective role of S-allylcysteine |
| Q73304376 | Loss of cannabinoid CB(1) receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington's disease |
| Q45305400 | Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease |
| Q43061451 | Mechanisms underlying striatal vulnerability to 3-nitropropionic acid |
| Q39262630 | Metabolic Compromise with Systemic 3-Nitropropionic Acid Produces Striatal Apoptosis in Sprague–Dawley Rats but Not in BALB/c ByJ Mice |
| Q50358016 | Mitochondria toxin-induced acute cochlear cell death indicates cellular activity-correlated energy consumption |
| Q37418288 | Mitochondrial calcium function and dysfunction in the central nervous system |
| Q33580327 | Mitochondrial matters of the brain: the role in Huntington's disease |
| Q28360954 | Mitochondrial toxin 3-nitropropionic acid induces cardiac and neurotoxicity differentially in mice |
| Q84118278 | NAP protects against cyanide-related microtubule destruction |
| Q45296399 | Neuroprotective activity of L-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum |
| Q36003847 | Neurotoxins and neurotoxic species implicated in neurodegeneration. |
| Q43122795 | Novel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington's-like symptoms: a comparative study |
| Q28346477 | Orphenadrine prevents 3-nitropropionic acid-induced neurotoxicity in vitro and in vivo |
| Q28661435 | Plants and phytochemicals for Huntington's disease |
| Q35710656 | Production of toxic metabolites in Aspergillus niger, Aspergillus oryzae, and Trichoderma reesei: justification of mycotoxin testing in food grade enzyme preparations derived from the three fungi |
| Q21245354 | Sequence variation in human succinate dehydrogenase genes: evidence for long-term balancing selection on SDHA |
| Q43509966 | Tauroursodeoxycholic acid partially prevents apoptosis induced by 3-nitropropionic acid: evidence for a mitochondrial pathway independent of the permeability transition |
| Q34786832 | The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects. |
| Q42448567 | The natural xanthone alpha-mangostin reduces oxidative damage in rat brain tissue |
| Q28278543 | Vinpocetine and α‐tocopherol prevent the increase in DA and oxidative stress induced by 3‐NPA in striatum isolated nerve endings |
| Q31924091 | White matter damage following systemic injection of the mitochondrial inhibitor 3-nitropropionic acid in rat. |
Search more.